Società Heron Therapeutics Inc OTC Bulletin Board
Azioni
APPAD
US4277461020
Biotecnologia
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutic Innovations
100,0
%
| 108 | 100,0 % | 127 | 100,0 % | +17,99% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 108 | 100,0 % | 127 | 100,0 % | +17,99% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/02/23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16/06/23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/11/18 |
Chief Tech/Sci/R&D Officer | 65 | 30/03/12 | |
John C. Arthur
PRN | Corporate Officer/Principal | 58 | 01/01/17 |
Sean T. Ristine
HRO | Human Resources Officer | 54 | 01/08/14 |
William Forbes
PRN | Corporate Officer/Principal | 62 | 06/06/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/02/23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20/09/21 |
Craig Johnson
BRD | Director/Board Member | 62 | 13/01/14 |
Christian Waage
BRD | Director/Board Member | 57 | 22/06/16 |
Adam Morgan
CHM | Chairman | 45 | 21/02/23 |
Director/Board Member | 49 | 20/09/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 150 653 158 | 149 597 060 ( 99,30 %) | 0 | 99,30 % |
Coordinate società
Heron Therapeutics, Inc.
4242 Campus Point Court Suite 200
92121, San Diego
+858 251 4400
http://www.herontx.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+24,74% | 47,54 Mrd | |
-0,47% | 41,96 Mrd | |
+48,04% | 41,55 Mrd | |
+25,40% | 30,36 Mrd | |
+17,96% | 27,61 Mrd | |
-4,47% | 28,7 Mrd | |
+50,73% | 14,7 Mrd | |
+42,56% | 13,51 Mrd | |
+1,46% | 12,34 Mrd |